Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$1.92M Hold
56,064
6% 1
2015
Q1
$1.85M Hold
56,064
5.7% 2
2014
Q4
$1.66M Sell
56,064
-24,536
-30% -$704K 5.01% 3
2014
Q3
$2.26M Sell
80,600
-81,210
-50% -$2.28M 4.18% 2
2014
Q2
$4.56M Buy
161,810
+39
+0% +$1.11K 3.57% 2
2014
Q1
$4.93M Hold
161,771
4.12% 2
2013
Q4
$4.79M Sell
161,771
-396,754
-71% -$11.5M 3.73% 2
2013
Q3
$15.2M Sell
558,525
-78,493
-12% -$2.14M 2.64% 9
2013
Q2
$16.9M Buy
+637,018
New +$17.6M 2.86% 6

Other funds holding PFE

Investors Trust's PFE Position: Q2 2015 in Review

Investors Trust held its Pfizer (PFE) position steady in Q2 2015 at 56,064 shares worth $1.92M. The position accounts for 6% of the portfolio, ranked #1.

Investors Trust first reported a position in PFE in Q2 2013 and has held it in 9 quarters since. The position peaked at $16.9M in Q2 2013. 1,887 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

  • Investors Trust held 56,064 shares of Pfizer worth $1.92M as of Q2 2015.
  • Investors Trust left its Pfizer share count unchanged in Q2 2015.
  • Pfizer made up 6% of Investors Trust's portfolio in Q2 2015, its #1 holding.
  • Investors Trust first reported a position in Pfizer in Q2 2013 and has held it in 9 quarters since.
  • Investors Trust's Pfizer position peaked at $16.9M in Q2 2013.
  • 1,887 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Investors Trust's 13F filing for Q2 2015, filed 14 Aug 2015.